Cord blood lipid correlation network profiles are associated with subsequent attention-deficit/hyperactivity disorder and autism spectrum disorder symptoms at 2 years: a prospective birth cohort study.
Saved in:
| Title: | Cord blood lipid correlation network profiles are associated with subsequent attention-deficit/hyperactivity disorder and autism spectrum disorder symptoms at 2 years: a prospective birth cohort study. |
|---|---|
| Authors: | Vacy K; Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville 3010, Australia; Melbourne School of Population and Global Health, University of Melbourne, Parkville 3010, Australia., Thomson S; Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville 3010, Australia., Moore A; Melbourne School of Mathematics and Statistics, University of Melbourne, Parkville 3010, Australia., Eisner A; Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville 3010, Australia., Tanner S; Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville 3010, Australia., Pham C; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville 3010, Australia; Department of Paediatrics, University of Melbourne, Parkville 3010, Australia., Saffery R; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville 3010, Australia; Department of Paediatrics, University of Melbourne, Parkville 3010, Australia., Mansell T; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville 3010, Australia; Department of Paediatrics, University of Melbourne, Parkville 3010, Australia., Burgner D; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville 3010, Australia; Department of Paediatrics, University of Melbourne, Parkville 3010, Australia; Department of Paediatrics, Monash University, Clayton 3168, Australia., Collier F; Child Health Research Unit, Barwon Health, Geelong 3220, Australia; School of Medicine, Deakin University, Geelong 3220, Australia., Vuillermin P; Child Health Research Unit, Barwon Health, Geelong 3220, Australia., O'Hely M; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville 3010, Australia; School of Medicine, Deakin University, Geelong 3220, Australia., Boon WC; Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville 3010, Australia., Meikle P; Metabolomics Laboratory, Baker Heart and Diabetes Institute, Melbourne 3004, Australia; Baker Department of Cardiovascular Research, Translation and Implementation, La Trobe University, Bundoora, VIC 3086, Australia., Burugupalli S; Metabolomics Laboratory, Baker Heart and Diabetes Institute, Melbourne 3004, Australia., Ponsonby AL; Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville 3010, Australia; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville 3010, Australia; Department of Paediatrics, University of Melbourne, Parkville 3010, Australia. Electronic address: annelouise.ponsonby@florey.edu.au. |
| Corporate Authors: | Barwon Infant Study Investigator Group |
| Source: | EBioMedicine [EBioMedicine] 2024 Feb; Vol. 100, pp. 104949. Date of Electronic Publication: 2024 Jan 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
